Zobrazeno 1 - 10
of 35
pro vyhledávání: '"R. Touzel"'
Quinagolide (CV 205-502, Sandoz), an octahydrobenzo (g) quinoline, is a new non-ergot dopamine agonist which has specific D2 receptor activity and a long half-life, making it suitable for once-daily treatment. Recent uncontrolled reports have suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9958fc30db798941707eee3a161a7fb3
https://ora.ox.ac.uk/objects/uuid:01c926dd-3fba-4f07-9382-ea9997ccd3d8
https://ora.ox.ac.uk/objects/uuid:01c926dd-3fba-4f07-9382-ea9997ccd3d8
Autor:
Linford Rees, J. A. H. Wass, M. Charlesworth, Martin O. Savage, R. Touzel, Ashley B. Grossman, G. M. Besser, Trevor A. Howlett, Piers N. Plowman
SUMMARY Fourteen patients presented with arrested pubertal development associated with prolactin-secreting pituitary tumours; serum prolactin ranged from 4000–104300 mU/1 in the ten females and 920–68000 in four males. Skull X-ray showed a marked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5859f5da61941a4f40734bf7bd366d42
https://doi.org/10.1111/j.1365-2265.1989.tb03734.x
https://doi.org/10.1111/j.1365-2265.1989.tb03734.x
Publikováno v:
Early Human Development. 35:167-172
Concentrations of prolactin were measured by an immunoradiometric assay in 26 matched samples of amniotic fluid, extraembryonic coelomic fluid and maternal serum from 9 to 12 weeks of pregnancy and in a further 131 amniotic fluid samples from 9 to 20
Autor:
S. Tsagarakis, R. Touzel, J. A. H. Wass, Arthur Jones, G. M. Besser, Ashley B. Grossman, Linford Rees, Piers N. Plowman
Publikováno v:
Clinical Endocrinology. 34:399-406
Summary objective To determine the long-term effects of external beam megavoltage radiotherapy (RT: 4500 cGy via three portals at 180 cGy or less total daily dose) on endocrine function in prolactinomas. design Longitudinal study following radiothera
Autor:
E. Ciccarelli, S. Tsagarakis, G. M. Besser, Martin O. Savage, Richard J. Ross, Peter J Trainer, J. M. W. Kirk, R. Touzel, Ashley B. Grossman
Publikováno v:
Scopus-Elsevier
Growth hormone-releasing hormone (GHRH) when given s.c. to GH-insufficient children either as pulses, or once or twice daily, promotes linear growth. These treatment regimens, however, are not ideal as they require frequent drug administration and a
Publikováno v:
Medical and pediatric oncology. 20(3)
Serum thyroglobulin has been measured serially in ten children aged 5-17 years presenting with differentiated thyroid carcinoma. At presentation 4 had intra-thyroidal disease, 3 had lymph node metastases, and 3 had lung metastases. During follow-up f
Autor:
Lorraine McLoughlin, L. Perry, L. H. Rees, G. M. Besser, R. Touzel, J. M. W. Kirk, Peter J Trainer
Publikováno v:
Scopus-Elsevier
Summary The reports of the effect of calcitonin on pituitary function are confusing and often refer to uncontrolled studies. We have now carried out a double-blind placebo-controlled trial of Intravenous and subcutaneous salmon calcitonin on anterior
Publikováno v:
Clinical endocrinology. 27(3)
The presence at presentation of hyperprolactinaemia and abnormalities on high resolution computed tomographic (CT) scanning of the pituitary gland have been documented in 19 patients with primary hypothyroidism. The changes on thyroid hormone replace
Publikováno v:
Fertility and sterility. 49(4)
Terguride, the C9-10 dihydrogenated derivative of lisuride, is a new drug which inhibits pituitary prolactin (PRL) secretion. It has mixed dopaminergic-antidopaminergic and alpha 2-antiadrenergic activity, and has proved useful in the clinical manage
Autor:
E. Ciccarelli, Salvatore Maria Corsello, J. A. H. Wass, Arthur Jones, G. M. Besser, LH Rees, Piers N. Plowman, R. Touzel
Publikováno v:
Acta endocrinologica. 121(6)
In 61 acromegalic patients, serum PRL was assessed (off medical treatment) before and 2 to 12 (mean 6.4) years after external beam radiotherapy. Before radiotherapy elevated PRL levels were present in 22 of 35 males (63%) and 12 of 26 females (46%) a